SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.

Highlights Shenzhen Weiguang Biological Products Co., Ltd.

Equities

002880

CNE100002Q58

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 03/06/2024 BST			5-day change	1st Jan Change
30.1 ^CNY	+1.69%		+0.27%	-14.32%

06-03	Weiguang Biological Products Gets Nod for Human Prothrombin Complex	MT
04-25	Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Weiguang Biological Products Gets Nod for Human Prothrombin Complex	06-03	MT
Shenzhen Weiguang Biological Products Co., Ltd. Approves Dividend for the Year 2023	05-20	CI
Shenzhen Weiguang Biological Products Co., Ltd. Proposes Final Cash Dividend for the Year 2023	04-26	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Weiguang Biological Products Gets Registration Certificate for Human Coagulation Factor VIII Drug	11-06	MT
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Announces Interim Profit Distribution Plan to Be Implemdented (A Shares) for 2023, Payable on 31 October 2023	24/10/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Announces Interim Dividend for Year 2023	18/09/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Proposes Interim Cash Dividend for the First Half of 2023	25/08/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23/08/23	CI
Weiguang Biological Products Halts Trading on Potential Change in Control	29/05/23	MT
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/04/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/04/23	CI
Weiguang Biological Products to Buy 80% of Plasma Collection Firm For 23 Million Yuan	10/01/23	MT
Shenzhen Weiguang Biological Products Co., Ltd. agreed to acquire 80% stake in Ankang Huitian Plasmapheresis Station Co., Ltd. from Xia Yuzhen for CNY 22.8 million	09/01/23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	29/10/22	CI
Shenzhen Weiguang Biological Products Co., Ltd. Announces Cash Dividend on A Shares for 2021, Payable on 8 July 2022	03/07/22	CI
Shenzhen Weiguang Biological Products Co., Ltd. Approves Cash Dividend for the Year 2021	13/05/22	CI
Shenzhen Weiguang Biological Products Co., Ltd. Proposes Final Cash Dividend for 2021	15/04/22	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/04/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Shenzhen Weiguang Biological Products Co., Ltd.

Equities

002880

CNE100002Q58

Highlights

Filters